News

New comms partnership between Agility Health Tech and Stevenage Bioscience Catalyst

Agility Health Tech is delighted to announce they are now managing the communications on behalf of Stevenage Bioscience Catalyst, marking an exciting development in the business relationship between the two organisations.

About Agility Health Tech

With over 25 years’ experience, Agility Health Tech is a full service consulting and communications agency specialising in the healthcare and life science sectors. From product development to business strategy and marcomms, Agility Health Tech can help advance your products and raise your profile.

3D Organoid Culture Crucial for Chromosome Segregation

AMSBIO reports on a recent published paper** by the Howard Hughes Medical Institute at the Massachusetts Institute of Technology (MIT) investigating why epithelial cells grown in monolayers on a plastic dish are worse at segregating their chromosomes than epithelial cells in vivo or in 3D organoid cultures.

New Scientist - One Nucleus Member Advertising Offer

We are happy to announce the below adversting offer from New Scientist for our members.

Individual Advertising

Standard Branded Advert - £299 (reduced from £599)
• Advert branded with logo live for up to 28 days

New collaboration between SLAS and One Nucleus

30 May 2019 - Cambridge UK:

BioIVT Named Service Provider for Promega Immunotherapy Bioassays

Demonstrating continuing support for immuno-oncology researchers, BioIVT extends excellence in research to help researchers screen novel therapeutics

Leaf Expression Systems Launch First Line of Hypertrans® Research Products

Plant-expression deal for difficult to produce proteins, vaccines, metabolites and natural proteins

29 May 2019: Norwich, UK Leaf Expression Systems, a contract development and manufacturing organisation specialising in the plant-based expression and production of proteins, vaccines, metabolites and complex natural proteins, has announced the launch of its online list of products available for purchase by researchers working within the life sciences and agricultural industries.

Sold out inaugural Bio Integrates conference a resounding success!

Following the continued success of Pharma Integrates, the inaugural Bio Integrates event took place on 22nd May in London. The sold-out conference hosted 315 delegates from across biotech, pharma, investment, charities and patient groups.

High Performance Feeder-Free Medium for Pluripotent Stem Cell Culture

AMSBIO introduces StemFit® Basic04, a next generation feeder-free medium for the maintenance of Induced Pluripotent Stem (iPS) and Embryonic Stem (ES) cells during the reprogramming, expansion and differentiation phases of stem cell culture. With its fully defined and animal-origin free formulation, StemFit® Basic04 is suited to both research studies and translation to cell therapy.

Catalent to Launch OneBio SuiteSM for Integrated Biologics Development, Manufacturing and Supply at BIO International 2019

SOMERSET, N.J. – May 23, 2019 — Catalent (Booth 3101), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, is to launch its new OneBio Suite^SM for the integrated development, manufacturing, and clinical supply of biologic drugs at the BIO International Convention, which takes place at the Pennsylvania Convention Center in Philadelphia, from June 3-6, 2019.

Dogma Therapeutics Emerges from Stealth Mode and Announces Oral PCSK9 Inhibitor Program

The word “undruggable” has hampered pursuit of the most compelling biological targets, drawing from established opinion that pharmacological modulation was not possible. Scientists at Dogma Therapeutics (“Dogma”) were determined to challenge this assumption. Dogma has discovered an orally-bioavailable small molecule PCSK9 inhibitor. By strategically focusing on small molecule inhibitors, Dogma can readily combine their compounds with current standard of care and dramatically disrupt the health economics of PCSK9-based therapies.

My Account